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（二） 然后,为了检测 MK 在不同人类肿瘤/癌症中的表达情况，我们使用
了 RT-PCR 的方法。实验选取的材料分别是人肺癌细胞系 A549，人胃腺癌
SGC-7901 细胞，人卵巢癌细胞系 8910，人成骨肉瘤细胞系 MG-63 这几种较为常
见的癌细胞系以及病人手术割弃的肝癌，肾癌，乳腺癌，直肠癌组织。为了提高
PCR 反应的灵敏度和专一性,我们采用了巢式(Nested)、直降（Touchdown）PCR















性肿瘤组织中都有很高的表达，（2）而且 MK 的截短型(truncated， tMK)在癌细
胞系恶性肿瘤组织中达到 100％的检出率（先前的检出率仅 60%左右）。已有不少





和 tMK 的表达，这与免疫组化的结果一样都证明了 MK 在癌症的发生、转移和侵
入中起到了重要的作用，因此 MK 及其 tMK 具有可开发为癌症的早期检测标志物
的可能性，这对于癌症肿瘤的有效检测与治疗都是非常有利的；（4）随后，用同
样的技术，由于灵敏度和专一性的提高，我们首次发现了在人癌症组织及其癌细
胞中，MK 的另外两种新截短型，分别称 tMKB 和 tMKC。之前己经发现并报道过的
这种截短型称 tMKA。它们的 mRNA 大小顺序是：tMKA > tMKB > tMKC。值得一提
的是，之前在小鼠胚胎中也发现 MK 的三种截短型，其剪切形式与本文中的三种
人类 tMK 十分相似；而疾病中的 tMK 又有明显变异。这可能为研究 MK 在病变中
的功能，提供重要线索；（5）一个显著的特点是，这些 tMK 的剪切位点序列具有
特异性，3’和 5’端剪切位点碱基序列完全相同，如 3’和 5’端剪切位点序列
都为-ACCCCC-。有趣的是这与之前在小鼠胚胎中发现的 3种新的 tMK 是类似的剪
切模式，也是具有此类序列专一性的 mRNA 剪切模式： 这提示着，可能存在一种
新型的 mRNA 剪切模式；（6）从基因结构上比较，tMKA 缺失了整个外显子 III，
tMKB 缺失了整个外显子 III 和 IV 的一部分，tMKC 缺失了外显子 III 和 IV 的各
一部分。对比之前在小鼠胚胎中也发现的三种 tMK，可能为挖掘 MK 在正常发育
和病变中的分子机制，提供新思路；（7）最后，我们运用实时定量（Real Time）






















































Midkine (MK)，a heparin binding growth/differentiation factor, belongs 
to Midkine family. Midkine family consists of only two members, namely 
midkine (MK) and pleiotrophin (PTN). MK is widely expressed during 
embryonic development and becomes restricted to kidney and small 
intestine epithelia in the adult. Aberrant MK expression has been reported 
in a variety of human tumor/cancer tissues. This abnormal expression is 
not tissue specific, resembling the expression pattern of p53. MK is 
involved in a variety  of biological functions, including promoting 
embryonic cell growth ,especially in the neural cells，and differentiation. 
In the adulthood it may play a hormonelike role in activating the 
differentiation of certain cells and maintaining the normal function of 
kidney. Besides, it is closely related with tcancer cell growth and 
differentiation. MK is becoming a novel molecular target for the 
tumor/cancer therapy. 
Some studies had suggested that MK expression is correlated with 
development of tumors/cancers, but few have revealed its spatiotemperal  
expression and histological information in the progression of diseases. 
We have first studied MK expression in human adult pancreatic tumor/cancer 
tissues by immunohistochemistry. (1) MK is significantly up-regulated in 
the disease tissues; (2) Notably, in the insulinoma it is highly expressed 
at the leading edge with the disease progression but has only low 
expression in the tumor body; (3) In the ductal adenocarcinoma, it is 
highly expressed in the invasive blood vessels, as well as in the abnormal 
islets and ducts; (4) Note in the advanced disease tissues, it shows 
aberrant expressions on some fast dividing cells in the expanded ductal 
epithelia.  
Interestingly it’s frequently expressed in the precancerous lesions. 















insulin-expressing cells. Alternatively, it may take part in the 
migration of insulin-expressing aberrant cells. The probable function of 
MK as a blood factor ,growth factor and its anti-apoptosis activity can 
be found obviously in the invasion and migration of ductal gland cancer 
(ductal carcinoma). That  implies that MK may increase the density of 
vessels and promote the growth of epithelia, which is very important for 
the progression of cancer. 
We then used RT-PCR to detect the expression of MK in different human 
tumor/cancer tissues. We first examined some human tumor/cancer cell 
lines, including A549 cells, SGC-7901 cells, human 8910 cells and MC-63 
cells and then several  surgically removed cancer tissues from liver, 
kidney, galactophore and rectum. To improve the sensitivity and 
specificity, we have employed nested and touchdown PCR strategy. (1), We 
havenot only confirmed some previous discoveries about MK’s high level 
expression in cancerous and malignant tumor tissues; (2) but also achieved 
100% detection of the expression of truncated MK in the disease specimens 
examined(the previous are only 60%). There are lots of reports that tMK 
is an aberrant form of MK lost of the N-terminal and part of the domain 
encoded by exon III. It is specifically expressed in tumor tissues and 
takes part in tumorigenesisThus, it is regarded as an effective marker 
for tumor detection.The simple method used in our experiment improves 
greatly the possibility of MK to be a marker of tumor detection. (3) In 
the peripheral cells of liver cancer tissues, we have also detected high 
_expression of MK and tMK. This coupled with the results from 
immunohistochemical staining suggests that MK may play an important role 
in tumorigenesis and metastasis. So MK and tMK could potentially be the 
early marker for tumor/cancer detection and this is very important for 
effective detection and therapy; (4) With the improvement in the 















MK, named tMKB and tMKC in addition totMKA, the previously reported one. 
The relative length of their mRNA is: tMKA> tMKB>tMKC. Interestedly，
we have previously reported three truncated MK in mouse embryo with 
similar alternative splicing schemes to those found in the above human 
disease tissues. By comparison, tMK shows some apperent mutation in the 
diseases, which may provide significant clue to the study about the 
function of MK in diseases; (5) One of the remarkable characteristics is 
that the sequences of their splicing sites have some unique sequence 
specificity:The 3’ sequence of the donor has the same sequence as the 
5’ sequence of the receptor at the splicing site. For example, both of 
the sequences of the splicing sites in 3'-end and 5'-end are -ACCCCC-. 
It's interesting that similar situations have been found in the three 
novel tMKs in mouse embryo. The similarity raises the possibility that 
there may exist a new mechanism of mRNA splicing;(6) Genetically, tMKA 
is resulted from the truncation of the whole extron III, tMKB from the 
whole extron III and a part of IV and tMKC from a part of extron III and 
a part of IV. Comparison with  the three types of truncated MKs found in 
mouse embryo, may shed light on the the molecule mechanisms of MK in the 
normal development and tumorigenesis/carcinogenesis; (7) We have applied 
Real-Time PCR to investigate quantitative relationship of MK & tMKA 
expression in normal, pre-disease and disease tissues. That has not only 
confirmed our previous findings but also laid a foundation for future 
application of MK detection in cancer/disease diagnosis and therapy. 
In summary, our studies have demonstrated that a methodology for high 
efficiency of MK detection in tumor/cancer diagnosis has been 
established.In addition, we have first discovered the three types of 
truncated MK to be specifically expressed in cancer/tumor tissues. 
Together, these have provided valuable information for further 
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